Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.040 | 10 | 93600739 | missense variant | A/T | snv |
|
0.800 | 1.000 | 3 | 1999 | 2012 | |||||||||
|
0.925 | 0.040 | 10 | 93600470 | missense variant | C/T | snv |
|
0.800 | 1.000 | 3 | 1999 | 2012 | |||||||||
|
1.000 | 10 | 93600692 | missense variant | C/T | snv |
|
0.800 | 0 | |||||||||||||
|
1.000 | 10 | 93600698 | missense variant | C/T | snv |
|
0.800 | 0 | |||||||||||||
|
0.925 | 0.080 | 10 | 93593997 | missense variant | A/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 10 | 93593997 | missense variant | A/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
10 | 93600270 | intron variant | A/C | snv | 0.40 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
10 | 93597029 | intron variant | T/G | snv | 0.10 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
10 | 93600666 | splice donor variant | C/A;G;T | snv |
|
0.700 | 0 | ||||||||||||||
|
1.000 | 10 | 93600917 | splice donor variant | C/A;G;T | snv |
|
0.700 | 0 | |||||||||||||
|
0.925 | 0.120 | 10 | 93601831 | intron variant | C/T | snv | 0.13 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2014 | 2016 | |||||||
|
0.925 | 0.040 | 10 | 93600739 | missense variant | A/T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
0.925 | 0.040 | 10 | 93600470 | missense variant | C/T | snv |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||||
|
10 | 93591553 | intron variant | A/C | snv | 0.24 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
0.827 | 0.160 | 10 | 93594018 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.160 | 10 | 93594018 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.160 | 10 | 93594018 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
Nervous System Diseases; Wounds and Injuries | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.160 | 10 | 93594018 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.827 | 0.160 | 10 | 93594018 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.827 | 0.160 | 10 | 93594018 | missense variant | C/T | snv | 4.0E-06 | 1.4E-05 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.080 | 10 | 93602293 | intron variant | T/G | snv | 0.18 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 10 | 93602293 | intron variant | T/G | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.120 | 10 | 93601831 | intron variant | C/T | snv | 0.13 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 10 | 93601831 | intron variant | C/T | snv | 0.13 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.120 | 10 | 93601831 | intron variant | C/T | snv | 0.13 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |